IP Library › Granted Patent US 9,345,803
Granted Patent B2
US 9,345,803 · App. 13/519,029 · Granted May 24, 2016

Absorbent material

Inventor: Colin Bradford (Keighley, GB)
Assignee: ADVANCED MEDICAL SOLUTIONS LIMITED
A61L15/46A61L15/225A61L2300/102A61L2300/104A61L2300/106A61L2300/206A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,345,803
App. No.
13/519,029
Granted
May 24, 2016
Kind
B2
Abstract

An absorbent product intended particularly for use as a wound dressing comprises an admixture of carboxymethyl chitosan and chitosan wherein the chitosan incorporates at least one antimicrobial agent. Absorbency is provided by the carboxymethyl chitosan and antimicrobial properties by the antimicrobial agent incorporated in the chitosan.

Claims (30)

1. A non-woven absorbent product comprising an admixture of

(i) 75-85% by weight of carboxymethyl chitosan fibres, and

(ii) 15-25% by weight of chitosan fibres incorporating at least one antimicrobial agent;

wherein the at least one antimicrobial agent is an insoluble compound and is only present in the chitosan fibres of (ii), said at least one antimicrobial agent being present at a level of 5-20% by weight based on the weight of chitosan fibres of (ii).

2. A product as claimed in claim 1 wherein the carboxymethyl chitosan has a degree of carboxymethylation in the range 0.3-1.4.

3. A product as claimed in claim 1 wherein the insoluble compound is a silver compound.

4. A product as claimed in claim 3 wherein the silver compound has a silver content of greater than 50% by weight as calculated on the basis of the chemical formula of the salt but excluding any water of crystallisation.

5. A product as claimed in claim 1 wherein the insoluble compound is a copper salt.

6. A product as claimed in claim 5 wherein the copper salt has a copper content of at least 33% by weight as calculated on the basis of the chemical formula of the salt but excluding any water of crystallisation.

7. A product as claimed in claim 1 wherein the insoluble compound is a salt of iodine.

8. A product as claimed in claim 1 wherein the chitosan contains EDTA or a salt thereof.

9. A product as claimed in claim 1 which comprises:

(i) about 80% by weight of the carboxymethyl chitosan fibres, and

(ii) about 20% by weight of the chitosan fibres containing the said at least one antimicrobial agent.

10. A product as claimed in claim 1 which is a needled felt.

11. A method of producing a non-woven absorbent product comprising an admixture of

(i) 75-85% by weight of carboxymethyl chitosan fibres, and

(ii) 15-25% by weight of chitosan fibres incorporating at least one antimicrobial agent;

wherein the at least one antimicrobial agent is an insoluble compound and is only present in the chitosan fibres of (ii), said at least one antimicrobial agent being present at a level of 5-20% by weight based on the weight of chitosan fibres of (ii), said method comprising the steps of:

(i) providing said carboxymethyl chitosan fibres;

(ii) providing said chitosan fibres incorporating said at least one antimicrobial agent; and

(iii) blending said carboxymethyl chitosan fibres and said chitosan fibres incorporating at least one antimicrobial agent to produce the absorbent product.

12. A method as claimed in claim 11 wherein said chitosan fibres incorporating said at least one antimicrobial agent are prepared by spinning a dope containing dissolved chitosan and an antimicrobial agent into a precipitation bath to produce fibres.

13. A method as claimed in claim 11 wherein said insoluble compound is a silver compound.

14. A method as claimed in claim 13 wherein the silver compound has a silver content of greater than 50% by weight as calculated on the basis of the chemical formula of the salt excluding any water of crystallisation.

15. A method as claimed in claim 12 wherein said insoluble compound is a copper salt.

16. A method as claimed in claim 15 wherein the copper salt has a copper content of at least 33% by weight of copper based on chemical formula of the salt but excluding any water of crystallisation.

17. A method as claimed in claim 11 wherein said chitosan fibres containing said at least one antimicrobial agent are prepared by spinning a dope containing dissolved chitosan into a precipitation bath to form fibres and treating said precipitated fibres with a treatment solution which contains an antimicrobial agent.

18. A method as claimed in claim 17 wherein the antimicrobial agent in said treatment solution is iodine and/or a salt of iodine.

19. A method as claimed in claim 18 wherein said antimicrobial agent in said treatment solution is PHMB.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2012
From: BRADFORD, COLIN
To: ADVANCED MEDICAL SOLUTIONS LIMITED
Reel/Frame 028612/0028 →
Priority Claims (1)
GB 0922664.8 · Dec 24, 2009 · national
Continuity (1)
Related Publication 20120276183A1 · Nov 1, 2012